Literature DB >> 8742774

Combining behavioral therapy and pharmacotherapy for smoking cessation: an update.

J R Hughes1.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 8742774

Source DB:  PubMed          Journal:  NIDA Res Monogr        ISSN： 1046-9516


× No keyword cloud information.
  6 in total

Review 1.  A meta-analysis of the efficacy of over-the-counter nicotine replacement.

Authors:  J R Hughes; S Shiffman; P Callas; J Zhang
Journal:  Tob Control       Date:  2003-03       Impact factor: 7.552

Review 2.  Distress tolerance and early smoking lapse.

Authors:  Richard A Brown; C W Lejuez; Christopher W Kahler; David R Strong; Michael J Zvolensky
Journal:  Clin Psychol Rev       Date:  2005-09

3.  Adherence to nicotine replacement therapy among pregnant smokers.

Authors:  Laura J Fish; Bercedis L Peterson; Rebecca J Namenek Brouwer; Pauline Lyna; Cheryl A Oncken; Geeta K Swamy; Evan R Myers; Pamela K Pletsch; Kathryn I Pollak
Journal:  Nicotine Tob Res       Date:  2009-04-07       Impact factor: 4.244

Review 4.  Cognitive enhancers for facilitating drug cue extinction: insights from animal models.

Authors:  Bríd Áine Nic Dhonnchadha; Kathleen M Kantak
Journal:  Pharmacol Biochem Behav       Date:  2011-02-02       Impact factor: 3.533

5.  Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Bosun Hong; Jonathan Livingstone-Banks; Hannah Wheat; Thomas R Fanshawe
Journal:  Cochrane Database Syst Rev       Date:  2019-06-05

6.  Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference-based, 52-week, follow-up trial.

Authors:  Alexios Politis; Vasileios Ioannidis; Konstantinos I Gourgoulianis; Zoe Daniil; Chrissi Hatzoglou
Journal:  Chron Respir Dis       Date:  2017-11-08       Impact factor: 2.444
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.